Developer docs
API playgroundTry for free, no card

Search company profiles

Cenduit

Full company profile

uuid000fets

Namestring
Cenduit
Legal namestring
IQVIA Inc.
Websiteurl
cenduit.com
Company typeenum
Public
Founded yearint
2007
Descriptiontext

Cenduit, LLC is a Durham, North Carolina-based clinical trial technology provider founded in 2007 that delivers customized patient randomization and drug supply management solutions to the pharmaceutical and biotech sectors. Its core offering is a cloud-based modular Randomization and Trial Supply Management (RTSM) system built on Interactive Response Technology (IRT), used by pharmaceutical sponsors and Contract Research Organizations (CROs) to assign treatments, manage investigational product (IP) supply chains, and maintain regulatory/audit compliance across trial phases. The company serves complex use cases including precision medicine, adaptive and decentralized trials, early-phase studies, and cell and gene therapy protocols requiring temperature-excursion management and kit traceability.

The platform is organized around configurable components: a Study Designer prototyping tool for rapid study build-out, a pre-built module library for simple-to-complex protocol adaptation, a mobile IP extension, and predictive algorithms for automated forecasting and resupply with direct-to-patient dispensation workflows. Technical differentiation centers on customizability and an integration surface cited at 400+ turnkey eClinical and drug-supply connections (eConsent, eCOA, site portal, DCT platforms). The supporting source material is served entirely under IQVIA branding, and the legal entity is identified as IQVIA Inc. (NYSE: IQV), indicating Cenduit now operates as an IRT solution within IQVIA's clinical technology portfolio rather than as a standalone brand.

The business model is enterprise B2B subscription/recurring: cloud-based RTSM delivered as a service bundled with expert consulting, study design, and ongoing support, sold via a sales-led, field/enterprise motion (demo requests, dedicated customer service, direct outreach) to large pharma sponsors and CROs. Pricing is quote-based and not publicly disclosed. Distribution is global, leveraging IQVIA's footprint across the Americas, Europe, Asia Pacific, and Middle East & Africa, with marketing driven by thought-leadership content, webinars, white papers, earned media, and customer case studies.

Short descriptiontext

Cenduit provides cloud-based Interactive Response Technology (IRT) for patient randomization and clinical trial drug supply management, serving pharmaceutical sponsors, biotechs, and CROs; now marketed under IQVIA's clinical technology portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial randomization, trial supply management, interactive response technology, patient randomization software, drug supply management
Industry2 codes
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAK
Clinical Trial Pharmacy & IMP Management at Site
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial RTSM / Interactive Response Technology Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1IRT Software Licensing and Services
TypeSubscription Recurring
Description

Cloud-based randomization and trial supply management solution provided as a service to pharmaceutical sponsors and CROs conducting clinical trials. The solution includes platform access, expert consulting services, and ongoing support for study design and deployment.

iqvia.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Cenduit provides a cloud-based Interactive Response Technology (IRT) / Randomization and Trial Supply Management (RTSM) platform that delivers customized patient randomization and investigational product (drug) supply management for clinical trials. The solution supports simple to complex protocols including precision medicine, adaptive, decentralized, and cell and gene therapy trials, combining study design tools, automated forecasting and resupply, traceability/temperature excursion management, and 400+ integrations with eClinical and drug supply systems for pharmaceutical sponsors, CROs, and biotech companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Save upwards of $20,000 a month through automated supply optimization
+2 more records
Product and service1 record
1IRT (Interactive Response Technology) / RTSM Platform
CategoryClinical Trial Technology / RTSM Software
Description

Cloud-based Interactive Response Technology / Randomization and Trial Supply Management platform that delivers customized patient randomization, investigational product (IP) supply management, automated forecasting and resupply, and traceability with 400+ eClinical integrations for pharmaceutical sponsors, CROs, and biotechnology companies running clinical trials across all phases and complexity levels.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medidata's RTSM/IRT module is part of the broader Medidata Platform and directly competes with Cenduit for enterprise pharma sponsor trials, particularly large Phase II/III programs.

TypeDirect peer
Description

Signant Health (formed from CRF Health and Bracket) provides RTSM alongside eCOA and eConsent, with comparable focus on complex trial designs and patient-centric workflows.

TypeDirect peer
Description

Veeva Vault Clinical Suite includes randomization and trial supply capabilities and competes head-to-head with Cenduit for enterprise pharma and biotech sponsors running complex protocols.

4Oracle Health Sciences (4G Clinical)
TypeDirect peer
Description

Oracle acquired 4G Clinical to add a leading RTSM solution to its Clinical One platform, directly competing with Cenduit across enterprise sponsor and CRO RFPs.

TypeDirect peer
Description

Suvoda is an IRT-specialist competing directly with Cenduit in randomization and trial supply management, with strong penetration in oncology and rare disease trials.

TypeDirect peer
Description

Almac's IXRS IRT platform competes directly with Cenduit and is frequently compared head-to-head in sponsor evaluations for randomization and clinical supply chain management.

TypeDirect peer
Description

Clario (formerly ERT/Bioclinica) provides clinical trial technology including randomization and supply management, competing with Cenduit across both large pharma and biotech segments.

TypeDirect peer
Description

Medrio's eClinical platform includes randomization and trial supply modules, often competing with Cenduit for mid-sized biotech and emerging sponsor customers.

TypeBroad incumbent
Description

Parexel is a global CRO with its own IRT/RTSM offering (Perceptive MyTrials), competing with Cenduit as part of bundled full-service trial execution versus standalone RTSM.

TypeBroad incumbent
Description

ICON is a top global CRO offering integrated RTSM within its full-service trial delivery, competing with Cenduit for both sponsor-direct contracts and CRO-mediated deployments.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cenduit

Clinical Trial RTSM / Interactive Response Technology Softwarecenduit.com

Cenduit provides cloud-based Interactive Response Technology (IRT) for patient randomization and clinical trial drug supply management, serving pharmaceutical sponsors, biotechs, and CROs; now marketed under IQVIA's clinical technology portfolio.

What Cenduit does

Cenduit, LLC is a Durham, North Carolina-based clinical trial technology provider founded in 2007 that delivers customized patient randomization and drug supply management solutions to the pharmaceutical and biotech sectors. Its core offering is a cloud-based modular Randomization and Trial Supply Management (RTSM) system built on Interactive Response Technology (IRT), used by pharmaceutical sponsors and Contract Research Organizations (CROs) to assign treatments, manage investigational product (IP) supply chains, and maintain regulatory/audit compliance across trial phases. The company serves complex use cases including precision medicine, adaptive and decentralized trials, early-phase studies, and cell and gene therapy protocols requiring temperature-excursion management and kit traceability.

The platform is organized around configurable components: a Study Designer prototyping tool for rapid study build-out, a pre-built module library for simple-to-complex protocol adaptation, a mobile IP extension, and predictive algorithms for automated forecasting and resupply with direct-to-patient dispensation workflows. Technical differentiation centers on customizability and an integration surface cited at 400+ turnkey eClinical and drug-supply connections (eConsent, eCOA, site portal, DCT platforms). The supporting source material is served entirely under IQVIA branding, and the legal entity is identified as IQVIA Inc. (NYSE: IQV), indicating Cenduit now operates as an IRT solution within IQVIA's clinical technology portfolio rather than as a standalone brand.

The business model is enterprise B2B subscription/recurring: cloud-based RTSM delivered as a service bundled with expert consulting, study design, and ongoing support, sold via a sales-led, field/enterprise motion (demo requests, dedicated customer service, direct outreach) to large pharma sponsors and CROs. Pricing is quote-based and not publicly disclosed. Distribution is global, leveraging IQVIA's footprint across the Americas, Europe, Asia Pacific, and Middle East & Africa, with marketing driven by thought-leadership content, webinars, white papers, earned media, and customer case studies.

Cenduit firmographics

Firmographics
Name
Cenduit
Legal name
IQVIA Inc.
Website
https://cenduit.com
Company type
Public
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Short description
Cenduit provides cloud-based Interactive Response Technology (IRT) for patient randomization and clinical trial drug supply management, serving pharmaceutical sponsors, biotechs, and CROs; now marketed under IQVIA's clinical technology portfolio.
Ownership category
akta.pro rank

Cenduit industry classification

Industry
Product category
Clinical Trial RTSM / Interactive Response Technology Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAK
Clinical Trial Pharmacy & IMP Management at Site

Keywords

  • Clinical trial randomization
  • Trial supply management
  • Interactive response technology
  • Patient randomization software
  • Drug supply management

Where Cenduit is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Markets served

Cenduit business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. IRT Software Licensing and Services: Cloud-based randomization and trial supply management solution provided as a service to pharmaceutical sponsors and CROs conducting clinical trials. The solution includes platform access, expert consulting services, and ongoing support for study design and deployment.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Cenduit product offering

Product offering

Core offering

Cenduit provides a cloud-based Interactive Response Technology (IRT) / Randomization and Trial Supply Management (RTSM) platform that delivers customized patient randomization and investigational product (drug) supply management for clinical trials. The solution supports simple to complex protocols including precision medicine, adaptive, decentralized, and cell and gene therapy trials, combining study design tools, automated forecasting and resupply, traceability/temperature excursion management, and 400+ integrations with eClinical and drug supply systems for pharmaceutical sponsors, CROs, and biotech companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • IRT (Interactive Response Technology) / RTSM Platform Cloud-based Interactive Response Technology / Randomization and Trial Supply Management platform that delivers customized patient randomization, investigational product (IP) supply management, automated forecasting and resupply, and traceability with 400+ eClinical integrations for pharmaceutical sponsors, CROs, and biotechnology companies running clinical trials across all phases and complexity levels.

Quantifiable outcome

  • Save upwards of $20,000 a month through automated supply optimization
  • +2 more outcomes

Companies that use Cenduit

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Cenduit technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Cenduit partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Cenduit competitors and assessment

Company assessment

Direct peers

  • Medidata (Dassault Systèmes): Medidata's RTSM/IRT module is part of the broader Medidata Platform and directly competes with Cenduit for enterprise pharma sponsor trials, particularly large Phase II/III programs.
  • Signant Health: Signant Health (formed from CRF Health and Bracket) provides RTSM alongside eCOA and eConsent, with comparable focus on complex trial designs and patient-centric workflows.
  • Veeva Systems: Veeva Vault Clinical Suite includes randomization and trial supply capabilities and competes head-to-head with Cenduit for enterprise pharma and biotech sponsors running complex protocols.
  • Oracle Health Sciences (4G Clinical): Oracle acquired 4G Clinical to add a leading RTSM solution to its Clinical One platform, directly competing with Cenduit across enterprise sponsor and CRO RFPs.
  • Suvoda: Suvoda is an IRT-specialist competing directly with Cenduit in randomization and trial supply management, with strong penetration in oncology and rare disease trials.
  • Almac Group: Almac's IXRS IRT platform competes directly with Cenduit and is frequently compared head-to-head in sponsor evaluations for randomization and clinical supply chain management.
  • Clario: Clario (formerly ERT/Bioclinica) provides clinical trial technology including randomization and supply management, competing with Cenduit across both large pharma and biotech segments.
  • Medrio: Medrio's eClinical platform includes randomization and trial supply modules, often competing with Cenduit for mid-sized biotech and emerging sponsor customers.

Broad incumbents

  • Parexel International: Parexel is a global CRO with its own IRT/RTSM offering (Perceptive MyTrials), competing with Cenduit as part of bundled full-service trial execution versus standalone RTSM.
  • ICON plc: ICON is a top global CRO offering integrated RTSM within its full-service trial delivery, competing with Cenduit for both sponsor-direct contracts and CRO-mediated deployments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Cenduit social profiles

Digital presence

Cenduit financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cenduit leadership team

Management profile

Number of profiles

Cenduit funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cenduit M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cenduit

What does Cenduit do?

Cenduit provides a cloud-based Interactive Response Technology (IRT) / Randomization and Trial Supply Management (RTSM) platform that delivers customized patient randomization and investigational product (drug) supply management for clinical trials. The solution supports simple to complex protocols including precision medicine, adaptive, decentralized, and cell and gene therapy trials, combining study design tools, automated forecasting and resupply, traceability/temperature excursion management, and 400+ integrations with eClinical and drug supply systems for pharmaceutical sponsors, CROs, and biotech companies.

Is Cenduit a public or private company?

Cenduit is a public company. It is classified as corporate owned and is currently operating.

When was Cenduit founded?

Cenduit was founded in 2007. It employs 101 to 250 people.

Where is Cenduit based?

Cenduit is headquartered in Durham, United States, in the North America region.

How does Cenduit make money?

One revenue line is on record: IRT Software Licensing and Services.

Who are Cenduit's main competitors?

Direct peers on record are Medidata (Dassault Systèmes), Signant Health, Veeva Systems, Oracle Health Sciences (4G Clinical), Suvoda, Almac Group, Clario and Medrio. Broad incumbents are Parexel International and ICON plc.

Does Cenduit have an API?

No public API is recorded for Cenduit.

What industry is Cenduit in?

Cenduit's product category is Clinical Trial RTSM / Interactive Response Technology Software. Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLAGACAK, Clinical Trial Pharmacy & IMP Management at Site. Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals